19-1206955-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000455.5(STK11):​c.42G>T​(p.Glu14Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000687 in 1,454,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E14G) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

STK11
NM_000455.5 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.21

Publications

0 publications found
Variant links:
Genes affected
STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
STK11 Gene-Disease associations (from GenCC):
  • familial pancreatic carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Peutz-Jeghers syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23008722).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000455.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STK11
NM_000455.5
MANE Select
c.42G>Tp.Glu14Asp
missense
Exon 1 of 10NP_000446.1
STK11
NM_001407255.1
c.42G>Tp.Glu14Asp
missense
Exon 1 of 9NP_001394184.1
STK11
NR_176325.1
n.1178G>T
non_coding_transcript_exon
Exon 1 of 11

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STK11
ENST00000326873.12
TSL:1 MANE Select
c.42G>Tp.Glu14Asp
missense
Exon 1 of 10ENSP00000324856.6
STK11
ENST00000652231.1
c.42G>Tp.Glu14Asp
missense
Exon 1 of 9ENSP00000498804.1
STK11
ENST00000585748.3
TSL:3
c.-82-11462G>T
intron
N/AENSP00000477641.2

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
6.87e-7
AC:
1
AN:
1454752
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
723070
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33368
American (AMR)
AF:
0.00
AC:
0
AN:
43696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25936
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39430
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84972
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52446
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
9.02e-7
AC:
1
AN:
1109072
Other (OTH)
AF:
0.00
AC:
0
AN:
60074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
31

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Hereditary cancer-predisposing syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.032
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.24
T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.23
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.23
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.63
N
PhyloP100
1.2
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
0.71
N
REVEL
Benign
0.061
Sift
Benign
0.20
T
Sift4G
Benign
0.34
T
Polyphen
0.0020
B
Vest4
0.25
MutPred
0.29
Gain of relative solvent accessibility (P = 0.1684)
MVP
0.73
MPC
0.91
ClinPred
0.46
T
GERP RS
2.8
PromoterAI
0.0060
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.11
gMVP
0.56
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs758769888; hg19: chr19-1206954; API